Wezenla 45 mg / 0.5 ml
Wezenla 45 mg / 0.5 ml is a medicine authorised by Swissmedic under authorisation number 70619. The authorisation holder is Amgen Switzerland AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 August 2026 and the authorisation is limited until 13 August 2031. ATC code L04AC05 places the medicine in the group Immunosuppressants.
| Authorisation number | 70619 |
|---|---|
| Name | Wezenla 45 mg / 0.5 ml |
| Full name | Wezenla 45 mg / 0.5 ml, Injektionslösung im Fertigpen |
| Authorisation holder | Amgen Switzerland AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | L04AC05 |
| First authorisation | 14 August 2026 |
| Authorisation validity | 13 August 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Wezenla 45 mg / 0.5 ml, Injektionslösung im Fertigpen | B | 14 August 2026 |
| 2 | Wezenla 90 mg / 1.0 ml, Injektionslösung im Fertigpen | B | 14 August 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Injektor(en), vorgefüllt/Pen | L04AC05 | 07.15.0. | B |
| 2 | 1 | Injektor(en), vorgefüllt/Pen | L04AC05 | 07.15.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Wezenla 45 mg / 0.5 ml authorised in Switzerland?
Yes. Wezenla 45 mg / 0.5 ml is authorised by Swissmedic under authorisation number 70619, data as of 01 September 2026. The authorisation is limited until 13 August 2031.
Which dispensing category does Wezenla 45 mg / 0.5 ml have?
Wezenla 45 mg / 0.5 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Wezenla 45 mg / 0.5 ml?
The authorisation holder is Amgen Switzerland AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.